Macmillan Cancer Support Trading Limited
Private Limited Company · London,
ActiveUnited KingdomIncorporated 1993Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£2
Cash
£1,008,656
Turnover
£3,062,168
Profit / loss
—
Current assets
£2,140,378
Creditors < 1 year
£2,140,376
Equity
£2
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £2 | £2 |
| Equity | £2 | £2 |
| Share capital | £2 | £2 |
| Assets | ||
| Current assets | £2,140,378 | £2,939,139 |
| Cash at bank | £1,008,656 | £1,661,633 |
| Debtors | £982,760 | £1,072,443 |
| Stock | £148,962 | £205,063 |
| Liabilities | ||
| Creditors within one year | £2,140,376 | £2,939,137 |
| Bank loans & overdrafts | £250,000 | £370,000 |
| Profit & loss | ||
| Turnover | £3,062,168 | £3,088,366 |
| Cost of sales | £877,033 | £802,599 |
| Gross profit | £2,185,135 | £2,285,767 |
| Operating profit | £1,278,915 | £1,287,966 |
| Interest receivable | £19,897 | £29,693 |
| Interest payable | £22,865 | £26,285 |
| Profit before tax | £1,275,947 | £1,291,374 |
| Operating costs | ||
| Audit fees | £10,000 | £9,623 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Macmillan Cancer Support
- Ultimate parent
- Macmillan Cancer Support
- Ultimate controlling party
- Macmillan Cancer Support
- Accounts
- Small company · FRS 102
- Approved
- 2026-07-28, signed by A Ashman
Turnover by segment (2)
- United Kingdom: 3,062,168 (2025-12-31)
- United Kingdom: 3,088,366 (2024-12-31)
Borrowings (1)
- Loan included in amounts owed to group undertakings · £250,000 · interest is charged monthly at a rate of 2% above Bank of England Base Rate · repayable on 31 December 2027 · secured on secured by a first ranking debenture dated 28 July 1999, containing fixed and floating charges on all the company's assets
Share classes (2)
- 2 Ordinary shares of £1 each of £1
- 2 Ordinary shares of £1 each of £1
Events after the year end (1)
- On 26 March 2026 Macmillan Cancer Support Trading Limited signed a contract to deliver a programme which aims to connect people diagnosed with long-term conditions with specialist Voluntary, Community and Social Enterprises (VCSE) at the point of diagnosis; the contract is due to be completed by 31 March 2028.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesAll Assets · created 1999-07-28
All monies
Outstanding